Erasca (NASDAQ: ERAS) reports about $341.8M in year-end 2025 cash

Rhea-AI Filing Summary

Erasca, Inc. reported preliminary year-end liquidity, stating that as of December 31, 2025, its cash, cash equivalents and marketable securities totaled approximately $341.8 million. This figure is based on unaudited internal information and management estimates and is part of the company’s results of operations and financial condition disclosure.

The company emphasized that this amount may change once it completes its year-end financial closing procedures and reviews of internal controls, and after its independent registered public accounting firm conducts its audit. The disclosure is deemed filed under the securities laws and is subject to the usual forward-looking statement cautions and risk factors referenced from prior SEC filings.

false 0001761918 0001761918 2026-01-20 2026-01-20

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 20, 2026

Erasca, Inc.

(Exact name of Registrant as Specified in Its Charter)

Delaware		001-40602		83-1217027
(State or Other Jurisdiction of Incorporation)		(Commission File Number)		(IRS Employer Identification No.)

3115 Merryfield Row Suite 300
San Diego, California		92121
(Address of Principal Executive Offices)		(Zip Code)

Registrant’s Telephone Number, Including Area Code: (858) 465-6511

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, $0.0001 par value per share		ERAS		Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 Results of Operations and Financial Condition.

Erasca, Inc. (the “Company”) is providing the following financial information. As of December 31, 2025, our cash, cash equivalents and marketable securities were approximately $341.8 million.

The cash, cash equivalents and marketable securities information above is based on preliminary unaudited information and management estimates for the year ended December 31, 2025, is not a comprehensive statement of our financial results as of and for the fiscal year ended December 31, 2025, and is subject to completion of our financial closing procedures. The Company’s independent registered public accounting firm has not conducted an audit or review of, and does not express an opinion or any other form of assurance with respect to, this preliminary estimate.

Pursuant to the rules and regulations of the SEC, the information provided in this Item 2.02 of this Form 8-K shall be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and shall be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, unless otherwise expressly set forth by specific reference in such a filing.

Forward-Looking Statements

The Company cautions you that statements contained in this report regarding matters that are not historical facts are forward-looking statements. The forward-looking statements are based on the Company’s current beliefs and expectations and include, but are not limited to: statements regarding the preliminary estimate of the Company’s cash, cash equivalents and marketable securities as of December 31, 2025. Actual results may differ from those set forth in this report due to the risks and uncertainties inherent in the Company’s business, including, without limitation: our actual results for the fourth quarter or full year of 2025 may differ materially from our preliminary estimates as a result of changes to assumptions and estimates, the completion of review of internal controls over financial reporting or other quarter-end and year-end procedures; and other risks described in the Company’s prior filings with the SEC, including under the heading “Risk Factors” in its annual report on Form 10-K for the year ended December 31, 2024, and any subsequent filings with the SEC. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof, and the Company undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement, which is made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

						Erasca, Inc.
Date: January 20, 2026				By:		/s/ Ebun Garner
						Ebun Garner, General Counsel

FAQ

What preliminary cash position did Erasca (ERAS) report as of December 31, 2025?

Erasca reported that, as of December 31, 2025, its cash, cash equivalents and marketable securities were approximately $341.8 million, based on preliminary unaudited information.

Is Erasca’s reported $341.8 million cash and investments figure audited?

No. The approximately $341.8 million in cash, cash equivalents and marketable securities is based on preliminary unaudited information and management estimates and is subject to completion of financial closing procedures.

Has Erasca’s independent auditor reviewed the preliminary 2025 cash figure?

Erasca stated that its independent registered public accounting firm has not conducted an audit or review of the preliminary cash, cash equivalents and marketable securities estimate and does not express any assurance on it.

What risks could cause Erasca’s actual 2025 results to differ from the preliminary estimate?

The company noted that actual results could differ due to changes in assumptions and estimates, completion of reviews of internal controls over financial reporting, other quarter-end and year-end procedures, and the broader risks described under “Risk Factors” in prior SEC filings.

How is this Erasca (ERAS) cash disclosure treated under U.S. securities laws?

The company stated that the information in this results of operations and financial condition disclosure is deemed “filed” under Section 18 of the Exchange Act and may be incorporated by reference into other Securities Act or Exchange Act filings.

Does Erasca plan to update these preliminary 2025 cash figures?

Erasca explained that all forward-looking statements, including the preliminary cash estimate, are subject to cautionary language and that it undertakes no obligation to update them, except as required by law.